GlassScriptPhysician profile
Sharon J Kim
NPI 1356795595
$2,492.90
in general payments reported to CMS, 2019-2025
23 companies · $497 in 2025
The $497 reported for 2025 was more than what 80% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $63.89 · 2021: $300 · 2022: $593 · 2023: $540 · 2024: $500 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,438 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,437.81 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $427.45 | 2021-2025 | |
| Astellas Pharma US INC | $378.59 | 2024-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $297.03 | 2021-2025 | |
| Therapeuticsmd, INC. | $241.53 | 2020-2022 | |
| Organon LLC | $239.76 | 2021-2025 | Nexplanon |
| Sumitomo Pharma America, INC. | $167.77 | 2023-2024 | Myfembree |
| Abbvie INC. | $160.44 | 2020-2023 | |
| Pfizer INC. | $120.78 | 2020-2024 | |
| Sage Therapeutics, LLC | $88.52 | 2025 | Zurzuvae |
| Renovia INC | $42.62 | 2021 | |
| Aspira Women'S Health INC | $41.43 | 2022-2023 | Ova1 |
| Supernus Pharmaceuticals, INC. | $39.47 | 2025 | Qelbree |
| Exact Sciences Corporation | $37.51 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Coopersurgical, INC. | $29.24 | 2022-2023 | Mara Console |
| Optumhealth Care Solutions, LLC | $26.99 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $23.89 | 2023 | Tirosint, Licart |
| Hologic Sales and Service, LLC | $22.81 | 2023 | Aptima |
| Myovant Sciences INC. | $21.38 | 2022 | |
| Lilly USA, LLC | $20.34 | 2025 | Zepbound |
| Exeltis, USA INC. | $19.80 | 2023 | Slynd |
| Evofem Biosciences, INC. | $16.45 | 2021 | |
| Shield Therapeutics INC | $15.95 | 2025 | |
| Scynexis, INC. | $13.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.